379 related articles for article (PubMed ID: 17936560)
1. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
[TBL] [Abstract][Full Text] [Related]
2. Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
Clegg HV; Itahana Y; Itahana K; Ramalingam S; Zhang Y
PLoS One; 2012; 7(5):e38212. PubMed ID: 22666487
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.
Tian H; Tackmann NR; Jin A; Zheng J; Zhang Y
J Biol Chem; 2017 Dec; 292(52):21614-21622. PubMed ID: 29123033
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
5. MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.
Chinnam M; Xu C; Lama R; Zhang X; Cedeno CD; Wang Y; Stablewski AB; Goodrich DW; Wang X
PLoS Genet; 2022 May; 18(5):e1010171. PubMed ID: 35588102
[TBL] [Abstract][Full Text] [Related]
6. MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail.
Sanford JD; Yang J; Han J; Tollini LA; Jin A; Zhang Y
BMC Mol Cell Biol; 2021 Sep; 22(1):46. PubMed ID: 34551723
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the p53 tumor suppressor pathway: the problems and promises of studying Mdm2's E3 ligase function.
Clegg HV; Zhang Y
Crit Rev Eukaryot Gene Expr; 2010; 20(1):77-86. PubMed ID: 20528739
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the Mdm2-p53 loop: ubiquitin is the key.
Clegg HV; Itahana K; Zhang Y
Cell Cycle; 2008 Feb; 7(3):287-92. PubMed ID: 18235222
[TBL] [Abstract][Full Text] [Related]
9. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
10. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
11. Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice.
Humpton TJ; Nomura K; Weber J; Magnussen HM; Hock AK; Nixon C; Dhayade S; Stevenson D; Huang DT; Strathdee D; Blyth K; Vousden KH
Genes Dev; 2021 Jan; 35(1-2):117-132. PubMed ID: 33334825
[TBL] [Abstract][Full Text] [Related]
12. PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2.
Choy MK; Movassagh M; Bennett MR; Foo RS
J Cell Physiol; 2010 Mar; 222(3):635-9. PubMed ID: 19950214
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage.
Tollini LA; Jin A; Park J; Zhang Y
Cancer Cell; 2014 Aug; 26(2):235-47. PubMed ID: 25117711
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 facilitates the association of p53 with the proteasome.
Kulikov R; Letienne J; Kaur M; Grossman SR; Arts J; Blattner C
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10038-43. PubMed ID: 20479273
[TBL] [Abstract][Full Text] [Related]
17. Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.
Wei J; Yang Y; Lu M; Xu L; Liu F; Yuan Z; Bao Q; Jiang Z; Xu X; Guo X; Zhang X; You Q; Sun H
Anticancer Agents Med Chem; 2015; 16(2):174-89. PubMed ID: 26343143
[TBL] [Abstract][Full Text] [Related]
18. The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo.
Huang L; Yan Z; Liao X; Li Y; Yang J; Wang ZG; Zuo Y; Kawai H; Shadfan M; Ganapathy S; Yuan ZM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12001-6. PubMed ID: 21730163
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish.
Chua JS; Liew HP; Guo L; Lane DP
Oncogene; 2015 Nov; 34(48):5933-41. PubMed ID: 25746004
[TBL] [Abstract][Full Text] [Related]
20. RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity.
Kawai H; Lopez-Pajares V; Kim MM; Wiederschain D; Yuan ZM
Cancer Res; 2007 Jul; 67(13):6026-30. PubMed ID: 17616658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]